{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:12:34Z","timestamp":1794737554792,"version":"4.9.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"48","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research Foundation\u2014Flanders"},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","award":["1127917N"],"award-info":[{"award-number":["1127917N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Limburg Clinical Research Program"},{"DOI":"10.13039\/501100009542","name":"Limburg Sterk Merk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Iron deficiency is common in heart failure with reduced ejection fraction (HFrEF) and negatively affects cardiac function and structure. The study the effect of ferric carboxymaltose (FCM) on cardiac reverse remodelling and contractile status in HFrEF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Symptomatic HFrEF patients with iron deficiency and a persistently reduced left ventricular ejection fraction (LVEF &amp;lt;45%) at least 6\u2009months after cardiac resynchronization therapy (CRT) implant were prospectively randomized to FCM or standard of care (SOC) in a double-blind manner. The primary endpoint was the change in LVEF from baseline to 3-month follow-up assessed by three-dimensional echocardiography. Secondary endpoints included the change in left ventricular end-systolic (LVESV) and end-diastolic volume (LVEDV) from baseline to 3-month follow-up. Cardiac performance was evaluated by the force\u2013frequency relationship as assessed by the slope change of the cardiac contractility index (CCI = systolic blood pressure\/LVESV index) at 70, 90, and 110 beats of biventricular pacing. A total of 75 patients were randomized to FCM (n\u2009=\u200937) or SOC (n\u2009=\u200938). At baseline, both treatment groups were well matched including baseline LVEF (34\u2009\u00b1\u20097 vs. 33\u2009\u00b1\u20098, P\u2009=\u20090.411). After 3\u2009months, the change in LVEF was significantly higher in the FMC group [+4.22%, 95% confidence interval (CI) +3.05%; +5.38%] than in the SOC group (\u22120.23%, 95% CI \u22121.44%; +0.97%; P\u2009&amp;lt;\u20090.001). Similarly, LVESV (\u22129.72\u2009mL, 95% CI \u221213.5\u2009mL; \u22125.93\u2009mL vs. \u22121.83\u2009mL, 95% CI \u22125.7\u2009mL; 2.1\u2009mL; P\u2009=\u20090.001), but not LVEDV (P\u2009=\u20090.748), improved in the FCM vs. the SOC group. At baseline, both treatment groups demonstrated a negative force\u2013frequency relationship, as defined by a decrease in CCI at higher heart rates (negative slope). FCM resulted in an improvement in the CCI slope during incremental biventricular pacing, with a positive force\u2013frequency relationship at 3\u2009months. Functional status and exercise capacity, as measured by the Kansas City Cardiomyopathy Questionnaire and peak oxygen consumption, were improved by FCM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Treatment with FCM in HFrEF patients with iron deficiency and persistently reduced LVEF after CRT results in an improvement of cardiac function measured by LVEF, LVESV, and cardiac force\u2013frequency relationship.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab411","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T11:12:28Z","timestamp":1623841948000},"page":"4905-4914","source":"Crossref","is-referenced-by-count":92,"title":["The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy\u2014the IRON-CRT trial"],"prefix":"10.1093","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6036-2113","authenticated-orcid":false,"given":"Pieter","family":"Martens","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Schiepse Bos 6 , Genk 3600, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0802-9508","authenticated-orcid":false,"given":"Matthias","family":"Dupont","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Schiepse Bos 6 , Genk 3600, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-3450","authenticated-orcid":false,"given":"Jeroen","family":"Dauw","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Schiepse Bos 6 , Genk 3600, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7325-7734","authenticated-orcid":false,"given":"Petra","family":"Nijst","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Schiepse Bos 6 , Genk 3600, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7784-3610","authenticated-orcid":false,"given":"Lieven","family":"Herbots","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jessa Ziekenhuis , Stadsomvaart 11, 3500 Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0821-4559","authenticated-orcid":false,"given":"Paul","family":"Dendale","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jessa Ziekenhuis , Stadsomvaart 11, 3500 Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Vandervoort","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Schiepse Bos 6 , Genk 3600, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6978-3002","authenticated-orcid":false,"given":"Liesbeth","family":"Bruckers","sequence":"additional","affiliation":[{"name":"Data Science Institute, Centrum for Statistics (CenStat), University Hasselt, Agoralaan building D, 3590 Diepenbeek, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"Wai Hong Wilson","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of cardiovascular medicine, Cleveland Clinic , 9500 Euclid Avenue, Desk J3-4, Cleveland, OH 44195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Schiepse Bos 6 , Genk 3600, Belgium"},{"name":"Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University , Agoralaan building C, 3590 Diepenbeek, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"2022102612015394900_ehab411-B1","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"2022102612015394900_ehab411-B2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"2022102612015394900_ehab411-B3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens","year":"2018","journal-title":"Acta Cardiol"},{"key":"2022102612015394900_ehab411-B4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2022102612015394900_ehab411-B5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ejhf.1174","article-title":"Cardiac iron deficiency-how to refuel the engine out of fuel","volume":"20","author":"Martens","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2022102612015394900_ehab411-B6","first-page":"362","article-title":"Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure","volume":"38","author":"Haddad","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102612015394900_ehab411-B7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ejhf.938","article-title":"Limited contractile reserve contributes to poor peak exercise capacity in iron-deficient heart failure","volume":"20","author":"Martens","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2022102612015394900_ehab411-B8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.hrthm.2007.09.009","article-title":"Early and late effects of cardiac resynchronization therapy on force-frequency relation and contractility regulating gene expression in heart failure patients","volume":"5","author":"Mullens","year":"2008","journal-title":"Heart Rhythm"},{"key":"2022102612015394900_ehab411-B9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/ehf2.12503","article-title":"Rationale and design of the IRON-CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy","volume":"6","author":"Martens","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2022102612015394900_ehab411-B10","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ehf2.12675","article-title":"The effect of iron deficiency on cardiac resynchronization therapy: results from the RIDE-CRT study","volume":"7","author":"Lacour","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2022102612015394900_ehab411-B11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.amjcard.2016.09.017","article-title":"Impact of iron deficiency on response to and remodeling after cardiac resynchronization therapy","volume":"119","author":"Martens","year":"2017","journal-title":"Am J Cardiol"},{"key":"2022102612015394900_ehab411-B12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2022102612015394900_ehab411-B13","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"2022102612015394900_ehab411-B14","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2022102612015394900_ehab411-B15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ehf2.12006","article-title":"Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency","volume":"1","author":"Ponikowski","year":"2014","journal-title":"ESC Heart Fail"},{"key":"2022102612015394900_ehab411-B16","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"2022102612015394900_ehab411-B17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jclinepi.2010.02.005","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"63","author":"Schulz","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"2022102612015394900_ehab411-B18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102612015394900_ehab411-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jer316","article-title":"EAE\/ASE recommendations for image acquisition and display using three-dimensional echocardiography","volume":"13","author":"Lang","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022102612015394900_ehab411-B20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0894-7317(03)00221-9","article-title":"Force-frequency relationship in the echocardiography laboratory: a noninvasive assessment of Bowditch treppe?","volume":"16","author":"Bombardini","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"2022102612015394900_ehab411-B21","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022102612015394900_ehab411-B22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/CS20040278","article-title":"Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration","volume":"109","author":"Dong","year":"2005","journal-title":"Clin Sci (Lond)"},{"key":"2022102612015394900_ehab411-B23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1249\/00005768-198604000-00002","article-title":"Effects of iron deficiency on endurance and muscle enzyme activity in man","volume":"18","author":"Celsing","year":"1986","journal-title":"Med Sci Sports Exerc"},{"key":"2022102612015394900_ehab411-B24","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/CIRCULATIONAHA.118.038516","article-title":"Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency","volume":"139","author":"Charles-Edwards","year":"2019","journal-title":"Circulation"},{"key":"2022102612015394900_ehab411-B25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.hfc.2010.03.003","article-title":"Molecular changes in myocardium in the course of anemia or iron deficiency","volume":"6","author":"Jankowska","year":"2010","journal-title":"Heart Fail Clin"},{"key":"2022102612015394900_ehab411-B26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ejhf.640","article-title":"Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis","volume":"19","author":"Melenovsky","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2022102612015394900_ehab411-B27","doi-asserted-by":"crossref","first-page":"e004800","DOI":"10.1161\/CIRCHEARTFAILURE.117.004800","article-title":"Skeletal muscle abnormalities and iron deficiency in chronic heart failure. An exercise (31)P magnetic resonance spectroscopy study of calf muscle","volume":"11","author":"Melenovsky","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2022102612015394900_ehab411-B28","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2006.07.015","article-title":"Intravenous iron alone for the treatment of anemia in patients with chronic heart failure","volume":"48","author":"Bolger","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2022102612015394900_ehab411-B29","first-page":"236","article-title":"Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency","volume":"21","author":"Usmanov","year":"2008","journal-title":"J Nephrol"},{"key":"2022102612015394900_ehab411-B30","doi-asserted-by":"crossref","first-page":"e014254","DOI":"10.1161\/JAHA.119.014254","article-title":"Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the myocardial-IRON trial","volume":"9","author":"Nunez","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2022102612015394900_ehab411-B31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ehf2.12101","article-title":"Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study","volume":"3","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"ESC Heart Fail"},{"key":"2022102612015394900_ehab411-B32","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ejhf.2046","article-title":"Optimized Implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: a joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022102612015394900_ehab411-B33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2022102612015394900_ehab411-B34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jcmg.2015.12.020","article-title":"Transthoracic 3D echocardiographic left heart chamber quantification using an automated adaptive analytics algorithm","volume":"9","author":"Tsang","year":"2016","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/48\/4905\/46643968\/ehab411.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/48\/4905\/46643968\/ehab411.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T12:06:03Z","timestamp":1666785963000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/48\/4905\/6310469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":34,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2021,6,29]]},"published-print":{"date-parts":[[2021,12,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab411","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,21]]},"published":{"date-parts":[[2021,6,29]]}}}